Dantrolene and potentially fatal hyperthermia secondary to L-asparaginase.
D000293:Adolescent; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001215:Asparaginase / Q000009:adverse effects*; D003620:Dantrolene / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005334:Fever / Q000139:chemically induced* / Q000188:drug therapy; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D008297:Male
D000970:Antineoplastic Agents; D001215:Asparaginase; D003620:Dantrolene